Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...
Children with MS who have more paramagnetic rim lesions, or chronic inflammation, tend to show faster declines in brain ...
Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...
New research reveals a strong link between persistent brain inflammation and early brain shrinkage in children with MS. These ...
FLAMeS, a new convolutional neural network, enhances MS lesion segmentation accuracy using only T2-weighted FLAIR images, ...
The faster patients can be diagnosed with multiple sclerosis, the sooner they can begin taking the powerful medications that ...
Teriflunomide (Aubagio, Genzyme/Sanofi), a once-daily oral medication approved for relapsing-remitting multiple sclerosis (RRMS), significantly slows brain volume loss in these patients, a reanalysis ...
Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback